Log In
Print
BCIQ
Print
Print this Print this
 

Infradure

  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionAutologous tissue explants that deliver sustained interferon (IFN) alpha using Medgenics' biopump technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today